Insider Transactions in Q4 2024 at Azenta, Inc. (AZTA)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 05
2024
|
Lawrence Y. Lin EVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
28,813
+28.93%
|
$1,296,585
$45.0 P/Share
|
Dec 04
2024
|
David Dong Wang SVP & GM, SMS |
SELL
Sale (or disposition) back to the issuer
|
Direct |
140
-0.58%
|
$6,440
$46.65 P/Share
|
Nov 19
2024
|
Herman Cueto EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
712
-2.89%
|
$28,480
$40.07 P/Share
|
Nov 19
2024
|
Jason Joseph SVP, General Counsel, Secy. |
SELL
Open market or private sale
|
Direct |
1,139
-1.0%
|
$45,560
$40.07 P/Share
|
Nov 19
2024
|
David Dong Wang SVP & GM, SMS |
SELL
Open market or private sale
|
Direct |
348
-1.42%
|
$13,920
$40.07 P/Share
|
Nov 19
2024
|
Ginger Zhou SVP and General Manager, Genom |
SELL
Open market or private sale
|
Direct |
491
-1.75%
|
$19,640
$40.07 P/Share
|
Nov 19
2024
|
Violetta Hughes VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
163
-1.62%
|
$6,520
$40.07 P/Share
|
Nov 19
2024
|
Olga Pirogova SVP and CHRO |
SELL
Open market or private sale
|
Direct |
548
-2.75%
|
$21,920
$40.07 P/Share
|
Nov 19
2024
|
John Marotta President and CEO |
BUY
Open market or private purchase
|
Direct |
1,250
+1.22%
|
$50,000
$40.67 P/Share
|
Nov 19
2024
|
Martin D Madaus |
BUY
Open market or private purchase
|
Direct |
4,940
+40.02%
|
$197,600
$40.77 P/Share
|
Nov 18
2024
|
Didier Hirsch |
BUY
Open market or private purchase
|
Direct |
1,000
+22.4%
|
$39,000
$39.5 P/Share
|
Nov 18
2024
|
William L Cornog |
BUY
Open market or private purchase
|
Indirect |
12,500
+45.86%
|
$487,500
$39.6 P/Share
|
Nov 18
2024
|
John Marotta President and CEO |
BUY
Open market or private purchase
|
Direct |
12,716
+11.32%
|
$495,924
$39.48 P/Share
|
Nov 15
2024
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
8,651
+23.61%
|
$354,691
$41.51 P/Share
|
Nov 15
2024
|
David Dong Wang SVP & GM, SMS |
BUY
Grant, award, or other acquisition
|
Direct |
8,651
+26.13%
|
$354,691
$41.51 P/Share
|
Nov 15
2024
|
Violetta Hughes VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,921
+40.7%
|
$283,761
$41.51 P/Share
|
Nov 15
2024
|
Jason Joseph SVP, General Counsel, Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
13,841
+10.85%
|
$567,481
$41.51 P/Share
|
Nov 15
2024
|
Olga Pirogova SVP and CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
10,381
+34.26%
|
$425,621
$41.51 P/Share
|
Nov 15
2024
|
John Marotta President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
83,622
+49.04%
|
$3,428,502
$41.51 P/Share
|
Nov 06
2024
|
Alan J Malus |
BUY
Sale (or disposition) back to the issuer
|
Direct |
995
+50.0%
|
$45,770
$46.52 P/Share
|
Nov 06
2024
|
William L Cornog |
SELL
Sale (or disposition) back to the issuer
|
Direct |
995
-30.62%
|
$45,770
$46.52 P/Share
|
Nov 06
2024
|
Quentin Koffey Director |
BUY
Grant, award, or other acquisition
|
Direct |
995
+50.0%
|
-
|
Oct 17
2024
|
Herman Cueto EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,595
-6.09%
|
$68,585
$43.68 P/Share
|